SMI

SMI handeln
14.269,46 PKT +45,56 PKT +0,32 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 969000

ISIN CH0009980894


Analysen zu SMI-Werten

Datum Rating Analyst
07.11.19 Zurich Insurance overweight JP Morgan Chase & Co.
07.11.19 Zurich Insurance buy Goldman Sachs Group Inc.
07.11.19 Roche buy UBS AG
06.11.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
06.11.19 ABB (Asea Brown Boveri) Sector Perform RBC Capital Markets
04.11.19 Holcim overweight Morgan Stanley
04.11.19 UBS buy Goldman Sachs Group Inc.
04.11.19 Givaudan Sell Goldman Sachs Group Inc.
01.11.19 Swiss Re Sell UBS AG
01.11.19 Swiss Re overweight JP Morgan Chase & Co.
01.11.19 Swiss Re Sector Perform RBC Capital Markets
01.11.19 UBS buy Kepler Cheuvreux
01.11.19 Swiss Re kaufen Credit Suisse Group
31.10.19 Swiss Re Sector Perform RBC Capital Markets
31.10.19 Swiss Re overweight JP Morgan Chase & Co.
31.10.19 Swiss Re overweight Barclays Capital
31.10.19 Swiss Re buy Goldman Sachs Group Inc.
31.10.19 Novartis Hold Deutsche Bank AG
31.10.19 UBS buy Deutsche Bank AG
31.10.19 Swiss Re Sell UBS AG
31.10.19 UBS Neutral JP Morgan Chase & Co.
30.10.19 Holcim buy Goldman Sachs Group Inc.
30.10.19 Givaudan Sell Goldman Sachs Group Inc.
30.10.19 UBS buy Goldman Sachs Group Inc.
30.10.19 UBS Equal weight Barclays Capital
30.10.19 UBS Neutral JP Morgan Chase & Co.
30.10.19 UBS Equal weight Barclays Capital
30.10.19 UBS Equal-Weight Morgan Stanley
30.10.19 UBS Sector Perform RBC Capital Markets
30.10.19 Novartis Underweight JP Morgan Chase & Co.
30.10.19 UBS buy UBS AG
30.10.19 Holcim overweight JP Morgan Chase & Co.
29.10.19 Holcim Equal weight Barclays Capital
29.10.19 ABB (Asea Brown Boveri) Underweight JP Morgan Chase & Co.
28.10.19 Holcim overweight JP Morgan Chase & Co.
26.10.19 UBS Neutral Goldman Sachs Group Inc.
25.10.19 Novartis Underweight Barclays Capital
25.10.19 Holcim Neutral UBS AG
24.10.19 Novartis Neutral UBS AG
24.10.19 Novartis Conviction Buy List Goldman Sachs Group Inc.

* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.